| Record ID | marc_records_scriblio_net/part22.dat:149202010:1220 |
| Source | Scriblio |
| Download Link | /show-records/marc_records_scriblio_net/part22.dat:149202010:1220?format=raw |
LEADER: 01220pam 2200337 a 4500
001 92005759
003 DLC
005 19920716142922.4
008 920320s1992 mdua b 001 0 eng c
010 $a 92005759
020 $a0683002546
040 $aDNLM/DLC$cDLC$dDLC
050 00 $aRC271.C5$bH54 1992
060 $aQZ 267 H638
082 00 $a616.99/4061$220
245 00 $aHigh-dose cancer therapy :$bpharmacology, hematopoietins, stem cells /$cedited by James O. Armitage, Karen H. Antman.
260 $aBaltimore :$bWilliams & Wilkins,$cc1992.
300 $axxi, 816 p. :$bill. ;$c26 cm.
504 $aIncludes bibliographical references and index.
650 0 $aCancer$xChemotherapy.
650 0 $aCancer$xChemotherapy$xComplications$xPrevention.
650 0 $aDrugs$xDosage.
650 0 $aHematopoietic growth factors$xTherapeutic use.
650 0 $aBone marrow$xEffect of drugs on.
650 2 $aAntineoplastic Agents$xadministration & dosage.
650 2 $aDose-Response Relationship, Drug.
650 2 $aHematopoietic Cell Growth Factors$xtherapeutic use.
650 2 $aNeoplasms$xdrug therapy.
700 10 $aArmitage, James O.,$d1946-
700 10 $aAntman, Karen.
740 01 $aHigh dose cancer therapy.